Esophageal cancer is the sixth most common cause of cancer-related death worldwide.
Esophageal adenocarcinoma is the most common subtype of esophageal cancer in the …

Gastric cancer is one of the most frequent and deadly tumours worldwide. However, the
evidence that currently exists for the treatment of older adults is limited and is derived mainly …

METHODS: Patients who underwent EET for T1a EAC at 3 referral Barrett's esophagus
endotherapy units between 1996 and 2022 were included. Patients with submucosal …

Background Management following endoscopic submucosal dissection (ESD) of pT1b
esophageal adenocarcinoma (EAC) remains controversial. This study compared …

Using a systematic literature search of original articles published during 2022 in
Gastrointestinal Endoscopy and other high-impact medical and gastroenterology journals …

Abstract Background and Aims Endoscopic submucosal dissection (ESD) is a technically
challenging and time-consuming procedure. A major limitation of ESD is the lack of a …

Esophageal cancer ranks among the most prevalent malignant tumors globally, primarily
due to its highly aggressive nature and poor survival rates. According to the 2020 global …

Background & Aims Barrett's esophagus (BE) is the precursor to esophageal
adenocarcinoma (EAC). Endoscopic eradication therapy (EET) can be effective in …

Simple Summary Currently, it is unknown whether secondary esophagectomy after
endoscopic submucosal dissection (ESD) is comparable to primary esophagectomy. The …

The publication by Qu et al provided a comprehensive discussion about the epidemiology,
etiology, histopathology, early detection, and endoscopic treatment of esophageal …